“Technological Advancements and Increasing Plasma Fractionation Capacity”
- A prominent and growing trend in the Thailand blood plasma market is the adoption of advanced technologies in plasma collection, processing, and fractionation, aimed at improving product quality, safety, and yield. This trend is driven by the increasing demand for plasma-derived therapies to address chronic and rare diseases in the region
- For instance, in 2023, Bangkok-based plasma centers upgraded their collection systems with modern apheresis machines that enhance donor comfort and increase plasma yield, supporting the rising need for immunoglobulins and clotting factors
- Thailand’s key plasma fractionation facilities are investing in next-generation purification technologies such as chromatography and viral inactivation methods, complying with global quality standards and ensuring safer plasma-derived medicinal products (PDMPs) for both domestic use and export
- The government and private sector collaborations are also accelerating capacity expansion projects to reduce plasma product shortages, with several plasma collection centers expanding their donor base through awareness campaigns and improved donor screening processes
- Furthermore, digital solutions like donor management software and traceability systems are being increasingly implemented to optimize plasma collection logistics and maintain compliance with regulatory frameworks enforced by the Thai Food and Drug Administration (FDA)
- Emerging R&D efforts in Thailand focus on developing innovative plasma therapies for autoimmune and rare genetic disorders, positioning the country as a potential hub for specialized plasma products in Southeast Asia
- This trend of technological modernization and capacity enhancement is strengthening Thailand’s plasma market infrastructure, improving patient access to critical therapies, and fostering growth opportunities for domestic and international plasma product manufacturer
